Neuromodulation and the Epidemiology of Magnetic Resonance Utilization for Lung, Breast, Colon, and Prostate Cancer.

Rohan JotwaniNeel MehtaEthesham BaigAjay GuptaAmitabh Gulati

Published in: Neuromodulation : journal of the International Neuromodulation Society (2020)

High likelihood of MRI within the oncologic context represents important distinction criteria for neuromodulation as patients may benefit from implantation of an MR conditional system.

Keyphrases

magnetic resonance
prostate cancer
contrast enhanced
end stage renal disease
radical prostatectomy
ejection fraction
chronic kidney disease
magnetic resonance imaging
newly diagnosed
risk factors
computed tomography
rectal cancer
patient reported outcomes
robot assisted